Atlas Trials

Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma

Clinical trial NCT04183569 · UNKNOWN

Trial details

NCT number
NCT04183569
Sponsor
University Hospital, Bordeaux
Status
UNKNOWN
Study type
OBSERVATIONAL
Lymphoma, Large B-Cell, Diffuse
Start date
2019-02-19
Primary completion
2020-05-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.